Evogene (EVGN) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Evogene (EVGN) over the last 12 years, with Q2 2025 value amounting to $6.4 million.
- Evogene's Total Non-Current Liabilities rose 3402.91% to $6.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.4 million, marking a year-over-year increase of 3402.91%. This contributed to the annual value of $6.3 million for FY2024, which is 5908.09% down from last year.
- Evogene's Total Non-Current Liabilities amounted to $6.4 million in Q2 2025, which was up 3402.91% from $6.3 million recorded in Q4 2024.
- In the past 5 years, Evogene's Total Non-Current Liabilities ranged from a high of $15.8 million in Q2 2023 and a low of $4.7 million during Q2 2024
- Moreover, its 5-year median value for Total Non-Current Liabilities was $6.3 million (2024), whereas its average is $9.1 million.
- As far as peak fluctuations go, Evogene's Total Non-Current Liabilities soared by 17672.96% in 2023, and later tumbled by 7005.68% in 2024.
- Quarter analysis of 5 years shows Evogene's Total Non-Current Liabilities stood at $6.0 million in 2021, then soared by 161.76% to $15.7 million in 2022, then decreased by 1.52% to $15.5 million in 2023, then tumbled by 59.08% to $6.3 million in 2024, then grew by 0.41% to $6.4 million in 2025.
- Its Total Non-Current Liabilities was $6.4 million in Q2 2025, compared to $6.3 million in Q4 2024 and $4.7 million in Q2 2024.